BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 216240)

  • 1. Elevation of high-density lipoprotein in epileptic patients treated with phenytoin.
    Nikkilä EA; Kaste M; Ehnholm C; Viikari J
    Acta Med Scand; 1978; 204(6):517-20. PubMed ID: 216240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum elevation of high density lipoprotein (HDL) cholesterol in epileptic patients taking carbamazepine or phenytoin.
    O'Neill B; Callaghan N; Stapleton M; Molloy W
    Acta Neurol Scand; 1982 Feb; 65(2):104-9. PubMed ID: 7072480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
    Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants.
    Luoma PV; Myllylä VV; Sotaniemi EA; Lehtinen IA; Hokkanen EJ
    Eur Neurol; 1980; 19(1):67-72. PubMed ID: 7371656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chronic phenytoin treatment on serum lipid profile in adult epileptic patients.
    Calandre EP; Sinués Porta B; García de la Calzada D
    Epilepsia; 1992; 33(1):154-7. PubMed ID: 1346382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma high-density lipoprotein cholesterol and anticonvulsant levels in epileptics.
    Luoma PV; Myllylä VV; Hokkanen E
    J Cardiovasc Pharmacol; 1982; 4(6):1024-7. PubMed ID: 6185767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma high-density lipoproteins and hepatic microsomal enzyme induction. Relation to histological changes in the liver.
    Luoma PV; Sotaniemi EA; Pelkonen RO; Arranto A; Ehnholm C
    Eur J Clin Pharmacol; 1982; 23(3):275-82. PubMed ID: 7173298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of serum high-density lipoprotein in phenytoin users.
    Nikkilä EA; Kaste M; Ehnholm C; Viikari J
    Br Med J; 1978 Jul; 2(6130):99. PubMed ID: 208710
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of low serum concentrations of high-density lipoprotein (HDL) cholesterol in TIA-patients treated with phenytoin.
    Kaste M; Muuronen A; Nikkilä EA; Neuvonen PJ
    Stroke; 1983; 14(4):525-30. PubMed ID: 6658926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phenytoin and valproic acid therapy on serum lipid levels and liver function tests.
    Dewan P; Aggarwal A; Faridi MM
    Indian Pediatr; 2008 Oct; 45(10):855-8. PubMed ID: 18948659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phenytoin on serum lipoproteins in middle-aged men.
    Kaukola S; Manninen V; Neuvonen PJ; Mälkönen M; Ehnholm C
    J Cardiovasc Pharmacol; 1981; 3(1):207-14. PubMed ID: 6160350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
    Phillips NR; Havel RJ; Kane JP
    Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum triglyceride and cholesterol levels during long-term phenytoin treatment for epilepsy.
    Luoma PV; Reunanen MI; Sotaniemi EA
    Acta Med Scand; 1979; 206(3):229-31. PubMed ID: 495231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum lipid and lipoprotein concentrations in chronic uremia.
    Norbeck HE; Orö L; Carlson LA
    Acta Med Scand; 1976; 200(6):487-92. PubMed ID: 189577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chlorthalidone on serum lipids and lipoproteins.
    Rosenthal T; Holtzman E; Segal P
    Atherosclerosis; 1980 May; 36(1):111-5. PubMed ID: 7387770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy.
    Nikolaos T; Stylianos G; Chryssoula N; Irini P; Christos M; Dimitrios T; Konstantinos P; Antonis T
    Med Sci Monit; 2004 Apr; 10(4):MT50-2. PubMed ID: 15039653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levels.
    Tutor-Crespo MJ; Hermida J; Tutor JC
    J Clin Pharmacol; 2004 Sep; 44(9):974-80. PubMed ID: 15317825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.